Artios

Developer of therapeutics targeting the deoxyribonucleic acid damage response in cancer

placeCambridge, England, United Kingdom calendar_todayFounded 2016 groups76 employees language artios.com

Registered entities

Investor mix

43 investors on record; lead investors include Andera Partners, Life Sciences Partners, SV Health Investors, Omega Funds.

Investor typeCountShare
Venture capital1228%
Private equity512%
Accelerator & incubator12%
Bank & private debt25%
Other / undisclosed2353%
Coming soon